Indications
This medicinal product is for diagnostic use only and the approved indication is scintigraphic imaging, in conjunction with other appropriate imaging modalities, for determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis. Scintimun should not be used for the diagnosis of diabetic foot infection.
Composition
- Active substance
- besilesomab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Scintimun
- Active substance
- besilesomab
- ATC code
- V09HA03
- Group
- Various
- Therapeutic area
- Osteomyelitis, Radionuclide Imaging
- Marketing authorisation holder
- Telix Innovations